MorrisonASJickHOryHW. Oral contraceptives and hepatitis: a report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet. 1977;8022:1142-1143.
2.
TsengAHills-NieminenC. Drug interactions between antiretrovirals and hormonal contraceptives. Expert Opin Drug Metab Toxicol. 2013;9:559-572.
3.
RobinsonJAJamshidiRBurkeAE. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol. 2012;2012:890160.
4.
MerryCBarryMGMulcahyF. Saquinavir pharmaco-kinetics alone and in combination with ritonavir in HIV-infected patients. AIDS. 1997;11:F29-F33.
5.
ElouniBBen SalemCZamyM. Cytolytic hepatitis possibly related to levonorgestrel/ethinylestradiol oral contra-ceptive use: 2 case reports. Ann Pharmacother. 2010;44:2035-2037. doi:10.1345/aph.1P201.
6.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
